Very solid and material announcement, total contracted revenue...

Very solid and material announcement, total contracted revenue up by +26% to 14.5m AUD

Was reading through their investor presso 10/9, plenty of upside left with the USA and Aussie market as @snouty pointed out. On top of that they have actually listed the past ,mergers and acquisition activities that has been happening over with their comparable peers. (as seen below, minimum 1-3 billions acquisition)

With the Biotech having its time to shine the past week, this will surely run up this week with today's late volume action, 10 cents easily with its 17 million market cap. Nice to be in a company which is already churning revenue rather than clinical / trial stages. I do own Volpara as well, and its proven to be one of my better long term buys Good to see that IME is doing a peer comparison against VHT.

Oh and forgot to mentioned their top 20 holds 82% of the company, very re-assuring if any material or substantial holding changes, plus it will not be tarnished by day traders with its limited supply of volume